Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	kinase activity	JAK2 TYRO3 SPHK2 AXL OBSCN AK9 FGFR4 PPIP5K2 TESK1 CDK4	4.58e-05	764	56	10	GO:0016301
GeneOntologyMolecularFunction	protein tyrosine kinase activity	JAK2 TYRO3 AXL FGFR4 TESK1	5.34e-05	145	56	5	GO:0004713
GeneOntologyMolecularFunction	phosphatidylinositol 3-kinase binding	JAK2 TYRO3 AXL	2.38e-04	43	56	3	GO:0043548
GeneOntologyMolecularFunction	transferase activity, transferring phosphorus-containing groups	JAK2 TYRO3 SPHK2 AXL OBSCN AK9 FGFR4 PPIP5K2 TESK1 CDK4	2.48e-04	938	56	10	GO:0016772
GeneOntologyMolecularFunction	phosphotransferase activity, alcohol group as acceptor	JAK2 TYRO3 SPHK2 AXL OBSCN FGFR4 TESK1 CDK4	7.65e-04	709	56	8	GO:0016773
GeneOntologyMolecularFunction	transmembrane receptor protein tyrosine kinase activity	TYRO3 AXL FGFR4	8.07e-04	65	56	3	GO:0004714
GeneOntologyBiologicalProcess	positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction	JAK2 TYRO3 MFHAS1 AXL AKR1C4 EXTL3 PLXNB1	1.71e-06	217	55	7	GO:0051897
GeneOntologyBiologicalProcess	regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction	JAK2 TYRO3 MFHAS1 AXL OBSCN AKR1C4 EXTL3 PLXNB1	2.73e-06	334	55	8	GO:0051896
GeneOntologyBiologicalProcess	phosphatidylinositol 3-kinase/protein kinase B signal transduction	JAK2 TYRO3 MFHAS1 AXL OBSCN AKR1C4 EXTL3 PLXNB1	7.32e-06	382	55	8	GO:0043491
MousePheno	abnormal c-wave shape	C3 C3AR1 SLC4A5	1.08e-06	7	45	3	MP:0012040
Domain	PROTEIN_KINASE_TYR	JAK2 TYRO3 AXL OBSCN FGFR4 TESK1	4.42e-07	97	56	6	PS00109
Domain	Tyr_kinase_AS	JAK2 TYRO3 AXL OBSCN FGFR4 TESK1	4.42e-07	97	56	6	IPR008266
Domain	fn3	TYRO3 IL12RB2 TSPOAP1 AXL OBSCN ROBO3	8.80e-06	162	56	6	PF00041
Domain	FN3	TYRO3 IL12RB2 TSPOAP1 AXL OBSCN ROBO3	1.87e-05	185	56	6	SM00060
Domain	FN3	TYRO3 IL12RB2 TSPOAP1 AXL OBSCN ROBO3	2.83e-05	199	56	6	PS50853
Domain	FN3_dom	TYRO3 IL12RB2 TSPOAP1 AXL OBSCN ROBO3	3.72e-05	209	56	6	IPR003961
Domain	Pkinase_Tyr	JAK2 TYRO3 AXL FGFR4 TESK1	4.19e-05	129	56	5	PF07714
Domain	Ser-Thr/Tyr_kinase_cat_dom	JAK2 TYRO3 AXL FGFR4 TESK1	5.78e-05	138	56	5	IPR001245
Domain	Protein_kinase_ATP_BS	JAK2 TYRO3 AXL OBSCN FGFR4 TESK1 CDK4	1.32e-04	379	56	7	IPR017441
Domain	TyrKc	JAK2 TYRO3 AXL FGFR4	1.40e-04	88	56	4	SM00219
Domain	Tyr_kinase_cat_dom	JAK2 TYRO3 AXL FGFR4	1.40e-04	88	56	4	IPR020635
Domain	-	TYRO3 IL12RB2 TSPOAP1 AXL OBSCN SIRPB2 FGFR4 ROBO3 PLXNB1	1.44e-04	663	56	9	2.60.40.10
Domain	Kinase-like_dom	JAK2 TYRO3 AXL OBSCN MACF1 FGFR4 TESK1 CDK4	1.99e-04	542	56	8	IPR011009
Domain	Ig-like_fold	TYRO3 IL12RB2 TSPOAP1 AXL OBSCN SIRPB2 FGFR4 ROBO3 PLXNB1	2.31e-04	706	56	9	IPR013783
Domain	Ig_I-set	TYRO3 AXL OBSCN FGFR4 ROBO3	2.59e-04	190	56	5	IPR013098
Domain	I-set	TYRO3 AXL OBSCN FGFR4 ROBO3	2.59e-04	190	56	5	PF07679
Domain	PROTEIN_KINASE_ATP	JAK2 TYRO3 AXL OBSCN FGFR4 TESK1 CDK4	4.24e-04	459	56	7	PS00107
Domain	Prot_kinase_dom	JAK2 TYRO3 AXL OBSCN FGFR4 TESK1 CDK4	6.18e-04	489	56	7	IPR000719
Domain	PROTEIN_KINASE_DOM	JAK2 TYRO3 AXL OBSCN FGFR4 TESK1 CDK4	6.48e-04	493	56	7	PS50011
Domain	IGc2	TYRO3 OBSCN SIRPB2 FGFR4 ROBO3	6.85e-04	235	56	5	SM00408
Domain	Ig_sub2	TYRO3 OBSCN SIRPB2 FGFR4 ROBO3	6.85e-04	235	56	5	IPR003598
Domain	IG	TYRO3 AXL OBSCN SIRPB2 FGFR4 ROBO3	1.59e-03	421	56	6	SM00409
Domain	Ig_sub	TYRO3 AXL OBSCN SIRPB2 FGFR4 ROBO3	1.59e-03	421	56	6	IPR003599
Domain	PLAT	DENND5B PKDREJ	1.79e-03	21	56	2	PS50095
Domain	-	DENND5B PKDREJ	1.79e-03	21	56	2	2.60.60.20
Domain	PLAT	DENND5B PKDREJ	1.79e-03	21	56	2	PF01477
Domain	PLAT/LH2_dom	DENND5B PKDREJ	1.79e-03	21	56	2	IPR001024
Domain	ig	TYRO3 AXL OBSCN FGFR4	2.52e-03	190	56	4	PF00047
Domain	Immunoglobulin	TYRO3 AXL OBSCN FGFR4	2.52e-03	190	56	4	IPR013151
Domain	IG_LIKE	TYRO3 AXL OBSCN SIRPB2 FGFR4 ROBO3	3.42e-03	491	56	6	PS50835
Domain	Ig-like_dom	TYRO3 AXL OBSCN SIRPB2 FGFR4 ROBO3	3.85e-03	503	56	6	IPR007110
Pubmed	An Eph-related receptor protein tyrosine kinase gene segmentally expressed in the developing mouse hindbrain.	JAK2 FGFR4 CDK4	8.61e-07	12	56	3	1281307
Pubmed	Microglia aggravate white matter injury via C3/C3aR pathway after experimental subarachnoid hemorrhage.	C3 C3AR1	2.55e-06	2	56	2	38866102
Pubmed	Dissociable effects of complement C3 and C3aR on survival and morphology of adult born hippocampal neurons, pattern separation, and cognitive flexibility in male mice.	C3 C3AR1	2.55e-06	2	56	2	34403734
Pubmed	C3a-C3aR signaling promotes breast cancer lung metastasis via modulating carcinoma associated fibroblasts.	C3 C3AR1	2.55e-06	2	56	2	31931851
Pubmed	Endothelial progenitor cell transplantation alleviated ischemic brain injury via inhibiting C3/C3aR pathway in mice.	C3 C3AR1	2.55e-06	2	56	2	31865842
Pubmed	Cyclic AMP plays a critical role in C3a-receptor-mediated regulation of dendritic cells in antigen uptake and T-cell stimulation.	C3 C3AR1	2.55e-06	2	56	2	18812470
Pubmed	Complement Component 3 Adapts the Cerebrospinal Fluid for Leptomeningeal Metastasis.	C3 C3AR1	2.55e-06	2	56	2	28283064
Pubmed	Hypothalamic but not pituitary or ovarian defects underlie the reproductive abnormalities in Axl/Tyro3 null mice.	TYRO3 AXL	2.55e-06	2	56	2	21539887
Pubmed	Defective engraftment of C3aR-/- hematopoietic stem progenitor cells shows a novel role of the C3a-C3aR axis in bone marrow homing.	C3 C3AR1	2.55e-06	2	56	2	19357704
Pubmed	Physical interaction between interleukin-12 receptor beta 2 subunit and Jak2 tyrosine kinase: Jak2 associates with cytoplasmic membrane-proximal region of interleukin-12 receptor beta 2 via amino-terminus.	JAK2 IL12RB2	2.55e-06	2	56	2	10198225
Pubmed	Complement Activation via a C3a Receptor Pathway Alters CD4+ T Lymphocytes and Mediates Lung Cancer Progression.	C3 C3AR1	2.55e-06	2	56	2	29118090
Pubmed	C3a and C3b activation products of the third component of complement (C3) are critical for normal liver recovery after toxic injury.	C3 C3AR1	2.55e-06	2	56	2	15240660
Pubmed	Identification of a selective nonpeptide antagonist of the anaphylatoxin C3a receptor that demonstrates antiinflammatory activity in animal models.	C3 C3AR1	2.55e-06	2	56	2	11342658
Pubmed	Downregulation of complement C3 and C3aR expression in subcutaneous adipose tissue in obese women.	C3 C3AR1	2.55e-06	2	56	2	24743347
Pubmed	Receptor for complement peptide C3a: a therapeutic target for neonatal hypoxic-ischemic brain injury.	C3 C3AR1	2.55e-06	2	56	2	23737250
Pubmed	Negative regulation of pulmonary Th17 responses by C3a anaphylatoxin during allergic inflammation in mice.	C3 C3AR1	2.55e-06	2	56	2	23285141
Pubmed	Upregulated flotillins and sphingosine kinase 2 derail AXL vesicular traffic to promote epithelial-mesenchymal transition.	SPHK2 AXL	2.55e-06	2	56	2	35394045
Pubmed	Deletion of the complement anaphylatoxin C3a receptor attenuates, whereas ectopic expression of C3a in the brain exacerbates, experimental autoimmune encephalomyelitis.	C3 C3AR1	2.55e-06	2	56	2	15383607
Pubmed	Mobilization studies in mice deficient in either C3 or C3a receptor (C3aR) reveal a novel role for complement in retention of hematopoietic stem/progenitor cells in bone marrow.	C3 C3AR1	2.55e-06	2	56	2	14604969
Pubmed	Complement component 3C3 and C3a receptor are required in chitin-dependent allergic sensitization to Aspergillus fumigatus but dispensable in chitin-induced innate allergic inflammation.	C3 C3AR1	2.55e-06	2	56	2	23549917
Pubmed	Complement pathway amplifies caspase-11-dependent cell death and endotoxin-induced sepsis severity.	C3 C3AR1	2.55e-06	2	56	2	27697835
Pubmed	The mouse anaphylatoxin C3a receptor: molecular cloning, genomic organization, and functional expression.	C3 C3AR1	2.55e-06	2	56	2	9164946
Pubmed	The complement C3-C3aR pathway mediates microglia-astrocyte interaction following status epilepticus.	C3 C3AR1	2.55e-06	2	56	2	33314324
Pubmed	The Complement C3a-C3a Receptor Axis Regulates Epithelial-to-Mesenchymal Transition by Activating the ERK Pathway in Pancreatic Ductal Adenocarcinoma.	C3 C3AR1	2.55e-06	2	56	2	35220210
Pubmed	Identification of novel protein kinases expressed in the myocardium of the developing mouse heart.	JAK2 TYRO3 FGFR4	4.42e-06	20	56	3	7893599
Pubmed	Complement-mediated inhibition of neovascularization reveals a point of convergence between innate immunity and angiogenesis.	C3 C3AR1	7.63e-06	3	56	2	20625009
Pubmed	Loss of decay-accelerating factor triggers podocyte injury and glomerulosclerosis.	C3 C3AR1	7.63e-06	3	56	2	32717081
Pubmed	brt, a mouse gene encoding a novel receptor-type protein-tyrosine kinase, is preferentially expressed in the brain.	TYRO3 AXL	7.63e-06	3	56	2	8108111
Pubmed	Identification of Axl as a downstream effector of TGF-β1 during Langerhans cell differentiation and epidermal homeostasis.	TYRO3 AXL	7.63e-06	3	56	2	23071254
Pubmed	TAM receptors are dispensable in the phagocytosis and killing of bacteria.	TYRO3 AXL	7.63e-06	3	56	2	19625016
Pubmed	TAM receptor ligands in lupus: protein S but not Gas6 levels reflect disease activity in systemic lupus erythematosus.	TYRO3 AXL	7.63e-06	3	56	2	20637106
Pubmed	High incidence of distal vaginal atresia in mice lacking Tyro3 RTK subfamily.	TYRO3 AXL	7.63e-06	3	56	2	18393392
Pubmed	Receptor tyrosine kinases Tyro3, Axl, and Mertk differentially contribute to antibody-induced arthritis.	TYRO3 AXL	7.63e-06	3	56	2	37537628
Pubmed	Complement component C3a plays a critical role in endothelial activation and leukocyte recruitment into the brain.	C3 C3AR1	7.63e-06	3	56	2	26822321
Pubmed	Association between peripheral blood WBCs C3aR mRNA level and plasma C3a, C3aR, IL-1β concentrations and acute exacerbation of chronic obstructive pulmonary disease.	C3 C3AR1	7.63e-06	3	56	2	34923262
Pubmed	The role of Tyro 3 subfamily receptors in the regulation of hemostasis and megakaryocytopoiesis.	TYRO3 AXL	7.63e-06	3	56	2	17488688
Pubmed	Systemic autoimmunity in TAM triple knockout mice causes inflammatory brain damage and cell death.	TYRO3 AXL	7.63e-06	3	56	2	23840307
Pubmed	Transplantation studies in C3-deficient animals reveal a novel role of the third complement component (C3) in engraftment of bone marrow cells.	C3 C3AR1	7.63e-06	3	56	2	15284858
Pubmed	Tyro3/Axl/Mertk-deficient mice develop bone marrow edema which is an early pathological marker in rheumatoid arthritis.	TYRO3 AXL	7.63e-06	3	56	2	30335822
Pubmed	Genome-scale CRISPR screening reveals that C3aR signaling is critical for rapid capture of fungi by macrophages.	C3 C3AR1	7.63e-06	3	56	2	36174103
Pubmed	Complement C3a-induced IL-17 plays a critical role in an IgE-mediated late-phase asthmatic response and airway hyperresponsiveness via neutrophilic inflammation in mice.	C3 C3AR1	7.63e-06	3	56	2	22539791
Pubmed	Receptor tyrosine kinases, TYRO3, AXL, and MER, demonstrate distinct patterns and complex regulation of ligand-induced activation.	TYRO3 AXL	7.63e-06	3	56	2	25074926
Pubmed	Functions of TAM RTKs in regulating spermatogenesis and male fertility in mice.	TYRO3 AXL	7.63e-06	3	56	2	19602523
Pubmed	Autocrine role for Gas6 with Tyro3 and Axl in leiomyosarcomas.	TYRO3 AXL	7.63e-06	3	56	2	23354874
Pubmed	The Ran binding protein RanBPM interacts with Axl and Sky receptor tyrosine kinases.	TYRO3 AXL	7.63e-06	3	56	2	15964779
Pubmed	TAM and TIM receptors mRNA expression in Zika virus infected placentas.	TYRO3 AXL	7.63e-06	3	56	2	33011564
Pubmed	Tyro-3 family receptors are essential regulators of mammalian spermatogenesis.	TYRO3 AXL	7.63e-06	3	56	2	10227296
Pubmed	Complement C3a regulates late asthmatic response and airway hyperresponsiveness in mice.	C3 C3AR1	7.63e-06	3	56	2	19684087
Pubmed	Macrophages and dendritic cells use different Axl/Mertk/Tyro3 receptors in clearance of apoptotic cells.	TYRO3 AXL	7.63e-06	3	56	2	17442946
Pubmed	TAM receptors and their ligand-mediated activation: Role in atherosclerosis.	TYRO3 AXL	7.63e-06	3	56	2	33234243
Pubmed	Post-translational modifications of the ligands: Requirement for TAM receptor activation.	TYRO3 AXL	7.63e-06	3	56	2	33234244
Pubmed	Recent advancements in role of TAM receptors on efferocytosis, viral infection, autoimmunity, and tissue repair.	TYRO3 AXL	7.63e-06	3	56	2	33234241
Pubmed	Natural killer cell differentiation driven by Tyro3 receptor tyrosine kinases.	TYRO3 AXL	7.63e-06	3	56	2	16751775
Pubmed	Immunological role of TAM receptors in the cancer microenvironment.	TYRO3 AXL	7.63e-06	3	56	2	33234245
Pubmed	TAM Receptors Are Not Required for Zika Virus Infection in Mice.	TYRO3 AXL	7.63e-06	3	56	2	28423319
Pubmed	TAM receptors in apoptotic cell clearance, autoimmunity, and cancer.	TYRO3 AXL	7.63e-06	3	56	2	23662598
Pubmed	The TAM receptor Mertk protects against neuroinvasive viral infection by maintaining blood-brain barrier integrity.	TYRO3 AXL	7.63e-06	3	56	2	26523970
Pubmed	TAM receptor tyrosine kinases: biologic functions, signaling, and potential therapeutic targeting in human cancer.	TYRO3 AXL	7.63e-06	3	56	2	18620092
Pubmed	Complement 3a induces the synapse loss via C3aR in mitochondria-dependent NLRP3 activating mechanisms during the development and progression of Alzheimer's disease.	C3 C3AR1	7.63e-06	3	56	2	39218048
Pubmed	TAM receptors support neural stem cell survival, proliferation and neuronal differentiation.	TYRO3 AXL	7.63e-06	3	56	2	25514676
Pubmed	Complement system is activated in stenotic aortic valves.	C3 C3AR1	7.63e-06	3	56	2	17498719
Pubmed	Expression and role of TYRO3 and AXL as potential therapeutical targets in leiomyosarcoma.	TYRO3 AXL	7.63e-06	3	56	2	29024938
Pubmed	New Insights into the Role of Tyro3, Axl, and Mer Receptors in Rheumatoid Arthritis.	TYRO3 AXL	7.63e-06	3	56	2	32051695
Pubmed	TAM receptor knockout mice are susceptible to retinal autoimmune induction.	TYRO3 AXL	7.63e-06	3	56	2	21467176
Pubmed	Development of a spontaneous liver disease resembling autoimmune hepatitis in mice lacking tyro3, axl and mer receptor tyrosine kinases.	TYRO3 AXL	7.63e-06	3	56	2	23799121
Pubmed	The association of Tyro3/Axl/Mer signaling with inflammatory response, disease activity in patients with primary Sjögren's syndrome.	TYRO3 AXL	7.63e-06	3	56	2	25881761
Pubmed	Gas6 receptors Axl, Sky and Mer enhance platelet activation and regulate thrombotic responses.	TYRO3 AXL	7.63e-06	3	56	2	15733062
Pubmed	H3K27 Methylation Dynamics during CD4 T Cell Activation: Regulation of JAK/STAT and IL12RB2 Expression by JMJD3.	JAK2 IL12RB2	7.63e-06	3	56	2	28947543
Pubmed	Transcriptome analysis of neural progenitor cells by a genetic dual reporter strategy.	TYRO3 AXL	7.63e-06	3	56	2	21805534
Pubmed	Antigen-presenting cell-derived complement modulates graft-versus-host disease.	C3 C3AR1	7.63e-06	3	56	2	22585573
Pubmed	Functional receptor for C3a anaphylatoxin is expressed by normal hematopoietic stem/progenitor cells, and C3a enhances their homing-related responses to SDF-1.	C3 C3AR1	7.63e-06	3	56	2	12511407
Pubmed	Activation of TYRO3/AXL tyrosine kinase receptors in thyroid cancer.	TYRO3 AXL	7.63e-06	3	56	2	21343401
Pubmed	Tyro3, Axl, and Mertk receptors differentially participate in platelet activation and thrombus formation.	TYRO3 AXL	7.63e-06	3	56	2	30541554
Pubmed	TYRO3 as a molecular target for growth inhibition and apoptosis induction in bladder cancer.	TYRO3 AXL	7.63e-06	3	56	2	30765874
Pubmed	Epithelial cell-directed efferocytosis in the post-partum mammary gland is necessary for tissue homeostasis and future lactation.	TYRO3 AXL	7.63e-06	3	56	2	21192804
Pubmed	Signaling through up-regulated C3a receptor is key to the development of experimental lupus nephritis.	C3 C3AR1	7.63e-06	3	56	2	16034139
Pubmed	TAM Family Receptor Kinase Inhibition Reverses MDSC-Mediated Suppression and Augments Anti-PD-1 Therapy in Melanoma.	TYRO3 AXL	7.63e-06	3	56	2	31451482
Pubmed	Increased soluble phagocytic receptors sMer, sTyro3 and sAxl and reduced phagocytosis in juvenile-onset systemic lupus erythematosus.	TYRO3 AXL	7.63e-06	3	56	2	25878564
Pubmed	Homeostatic regulation of the immune system by receptor tyrosine kinases of the Tyro 3 family.	TYRO3 AXL	7.63e-06	3	56	2	11452127
Pubmed	Increased hematopoietic cells in the mertk-/- mouse peritoneal cavity: a result of augmented migration.	TYRO3 AXL	7.63e-06	3	56	2	20483720
Pubmed	Complement C3 and C3aR mediate different aspects of emotional behaviours; relevance to risk for psychiatric disorder.	C3 C3AR1	7.63e-06	3	56	2	34543680
Pubmed	Deficiency of the Complement Component 3 but Not Factor B Aggravates Staphylococcus aureus Septic Arthritis in Mice.	C3 C3AR1	7.63e-06	3	56	2	26787717
Pubmed	Tyro3 family-mediated cell entry of Ebola and Marburg viruses.	TYRO3 AXL	7.63e-06	3	56	2	17005688
Pubmed	Complement component C3 is required for protective innate and adaptive immunity to larval strongyloides stercoralis in mice.	C3 C3AR1	7.63e-06	3	56	2	16547268
Pubmed	A dual-activity topoisomerase complex regulates mRNA translation and turnover.	JAK2 SPHK2 SZT2 MFHAS1 OBSCN NAV2 LRP3 EXTL3 TESK1 DHX30	9.50e-06	1105	56	10	35748872
Pubmed	The protein tyrosine kinase family of the human genome.	JAK2 TYRO3 AXL FGFR4	1.01e-05	83	56	4	11114734
Pubmed	Axon guidance receptor ROBO3 modulates subtype identity and prognosis via AXL-associated inflammatory network in pancreatic cancer.	AXL ROBO3	1.52e-05	4	56	2	35993361
Pubmed	C3a, C5a renal expression and their receptors are correlated to severity of IgA nephropathy.	C3 C3AR1	1.52e-05	4	56	2	24327134
Pubmed	Characterization of Gas6, a member of the superfamily of G domain-containing proteins, as a ligand for Rse and Axl.	TYRO3 AXL	1.52e-05	4	56	2	8621659
Pubmed	Role of Gas6 receptors in platelet signaling during thrombus stabilization and implications for antithrombotic therapy.	TYRO3 AXL	1.52e-05	4	56	2	15650770
Pubmed	Role of the Gas6/TAM System as a Disease Marker and Potential Drug Target.	TYRO3 AXL	1.52e-05	4	56	2	33532004
Pubmed	Astrocyte-microglia interaction drives evolving neuromyelitis optica lesion.	C3 C3AR1	1.52e-05	4	56	2	32568214
Pubmed	The Gas6/TAM System and Multiple Sclerosis.	TYRO3 AXL	1.52e-05	4	56	2	27801848
Pubmed	Increased sMer, but not sAxl, sTyro3, and Gas6 relate with active disease in juvenile systemic lupus erythematosus.	TYRO3 AXL	1.52e-05	4	56	2	31655933
Pubmed	Lung mesenchymal stromal cells influenced by Th2 cytokines mobilize neutrophils and facilitate metastasis by producing complement C3.	C3 C3AR1	1.52e-05	4	56	2	34707103
Pubmed	Heterogeneous nuclear ribonucleoprotein P2 is an autoantibody target in mice deficient for Mer, Axl, and Tyro3 receptor tyrosine kinases.	TYRO3 AXL	1.52e-05	4	56	2	16365397
Pubmed	Diversification of TAM receptor tyrosine kinase function.	TYRO3 AXL	1.52e-05	4	56	2	25194421
Pubmed	Gas6 and the Tyro 3 receptor tyrosine kinase subfamily regulate the phagocytic function of Sertoli cells.	TYRO3 AXL	1.52e-05	4	56	2	18159085
Pubmed	Molecular cloning and characterization of the human anaphylatoxin C3a receptor.	C3 C3AR1	1.52e-05	4	56	2	8702752
Pubmed	Sertoli cell-initiated testicular innate immune response through toll-like receptor-3 activation is negatively regulated by Tyro3, Axl, and mer receptors.	TYRO3 AXL	1.52e-05	4	56	2	20363878
GeneFamily	Fibronectin type III domain containing	TYRO3 IL12RB2 TSPOAP1 AXL OBSCN ROBO3	1.12e-06	160	39	6	555
GeneFamily	Receptor Tyrosine Kinases\|CD molecules	TYRO3 AXL FGFR4	8.68e-05	40	39	3	321
GeneFamily	Blood group antigens\|CD molecules\|I-set domain containing\|Immunoglobulin like domain containing	TYRO3 OBSCN FGFR4 ROBO3	3.91e-04	161	39	4	593
GeneFamily	Complement system\|Sushi domain containing	C3 C3AR1	2.73e-03	36	39	2	492
ToppCell	facs-Liver-Hepatocytes-24m-Myeloid\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	DNAAF3 AXL GINS2 C3AR1 SLC4A5	2.24e-06	168	56	5	4ae9e9d93bcd6f4d5815e57fd5afa7a3398a0ec1
ToppCell	Thalamus-Neuronal-Excitatory-eN2(Slc17a7_Slc17a6)-Slc17a7-Tac2-Excitatory_Neuron.Slc17a7.Tac2.Chat_(Habenular_cholinergic_cells)\|Thalamus / BrainAtlas - Mouse McCarroll V32	OBSCN FGFR4 ROBO3 PKDREJ	3.50e-06	82	56	4	51dd9ab3ddb26d3d3395d0c1a156a12a86caf89b
ToppCell	droplet-Lung-immune-endo-depleted-3m-Myeloid-plasmacytoid_dendritic_cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	RTL5 OBSCN ROBO3 PRSS36	5.02e-05	161	56	4	ed93cb6c133855a5c244821e1a260aae8ab4df9a
ToppCell	droplet-Lung-immune-endo-depleted-3m-Myeloid-Plasmacytoid_Dendritic\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	RTL5 OBSCN ROBO3 PRSS36	5.02e-05	161	56	4	0089d7bb305c592392791862a3341fc92af8f3e2
ToppCell	343B-Myeloid-Macrophage-SPP1+_Macrophage_3\|343B / Donor, Lineage, Cell class and subclass (all cells)	AXL OTUD1 LRP3 C3AR1	5.14e-05	162	56	4	0acb8f7b51bf422d4f4f8e99bd10360163ae4eb7
ToppCell	facs-Pancreas-Exocrine-18m-Epithelial-pancreatic_B_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	RTL5 PKDREJ SLX4 PLXNB1	5.27e-05	163	56	4	132aece9c79499b4bb3c2bde68d3d7202e1d8772
ToppCell	343B-Myeloid-Macrophage-SPP1+_Macrophage\|343B / Donor, Lineage, Cell class and subclass (all cells)	RTL5 ACOT11 C3AR1 PRSS36	5.39e-05	164	56	4	057ca87847373eff7fe97dd9f4358509e66ca4c3
ToppCell	TCGA-Ovary-Primary_Tumor-Ovarian_Carcinoma-Serous_Cystadenocarcinoma-5\|TCGA-Ovary / Sample_Type by Project: Shred V9	SZT2 ACOT11 OBSCN PLXNB1	5.65e-05	166	56	4	32d2eaf8a5d03881bf74d680825af2d5110b082d
ToppCell	droplet-Lung-LUNG-1m-Myeloid-dendritic_cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	JAK2 DNAAF3 GINS2 CASQ1	5.79e-05	167	56	4	e30e7ac8ea4399dc3c1d94fc6b857afc80a7a671
ToppCell	facs-Liver-Hepatocytes-24m-Myeloid-Kupffer_cell\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	DNAAF3 AXL C3AR1 SLC4A5	5.92e-05	168	56	4	04e168fe1d6f5f9e3d3bf9d7c13e800e3594868a
ToppCell	facs-Liver-Hepatocytes-24m-Myeloid-Kupffer_cell\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	DNAAF3 AXL C3AR1 SLC4A5	6.06e-05	169	56	4	454b92b9b67299a64278c010db033ca5b9d217a0
ToppCell	10x_3'_v2v3-Non-neoplastic-Myeloid-TAM-MG-TAM-MG_pro-infl_II-B\|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	AXL OTUD1 C3 C3AR1	6.06e-05	169	56	4	0867528101767fc65e93b3561480bf830c50368d
ToppCell	356C-Myeloid-Macrophage-SPP1+_Macrophage_4\|356C / Donor, Lineage, Cell class and subclass (all cells)	C3AR1 SIRPB2 PRSS36 SLX4	6.78e-05	174	56	4	75b3a852140fb726025c3c987143d67944afde2d
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive-Immune-Myeloid-Macrophage_Dendritic-M2_Macrophage\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	IL12RB2 RTL5 SIRPB2 PRSS36	7.41e-05	178	56	4	24e8c62060455159235985f456af0c5023a7f3f5
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive-Immune-Myeloid-Macrophage_Dendritic\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	IL12RB2 RTL5 SIRPB2 PRSS36	7.41e-05	178	56	4	4f1cc954d4d9b5b2b75a4cf995ba81e2ada27084
ToppCell	10x_3'_v2v3-Non-neoplastic-Myeloid-TAM-BDM-TAM-BDM_MHC-B\|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	AXL OTUD1 C3 C3AR1	8.07e-05	182	56	4	16186b7a0c33caa48631962381e3ab7e5d166163
ToppCell	facs-Brain_Non-Myeloid-Striatum-24m-Epithelial-nan\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	DNAAF3 TSPOAP1 C3 MYCBPAP	8.42e-05	184	56	4	264e14aa1859cfc0ed5fb40e97ea189aed9ef4a5
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive\|renal_medulla_nuclei / Celltypes from Cells and Nuclei per compartment and clinical group	MFHAS1 AXL MACF1 C3	8.42e-05	184	56	4	d2bf0135eb56bb410997dccea39c5ede88a0617f
ToppCell	facs-Brain_Non-Myeloid-Striatum-24m-Epithelial\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	DNAAF3 TSPOAP1 C3 MYCBPAP	8.42e-05	184	56	4	d7eccbd21c480d907fdc8eff2bf5ae22ae452221
ToppCell	facs-Brain_Non-Myeloid-Striatum-24m-Epithelial-neuroepithelial_cell\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	DNAAF3 TSPOAP1 C3 MYCBPAP	8.42e-05	184	56	4	22010cfe0428ebfa40952cc1a1a12ad3d25b35c9
ToppCell	BAL-Severe-Myeloid-Macrophage\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	ACOT11 SIRPB2 ROBO3 PRSS36	8.60e-05	185	56	4	ae966929fb5bbb08ffcbac76cb21941638727f55
ToppCell	BAL-Severe-Myeloid-Macrophage-transitional_Macro-\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	ACOT11 SIRPB2 ROBO3 PRSS36	8.60e-05	185	56	4	3beebaa92275086b1fae5f8c0c3d54016c5ba2aa
ToppCell	BAL-Severe-Myeloid-Macrophage-transitional_Macro-\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	ACOT11 SIRPB2 ROBO3 PRSS36	8.60e-05	185	56	4	ceff11cfa679147ccfd0a0f8079e697a6bea34d9
ToppCell	BAL-Severe-Myeloid-Macrophage\|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09)	ACOT11 SIRPB2 ROBO3 PRSS36	8.60e-05	185	56	4	9aea5ed8f9cee5ee933891203aac7adb85d68201
ToppCell	BAL-Severe-Myeloid-Macrophage-transitional_Macro\|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09)	ACOT11 SIRPB2 ROBO3 PRSS36	8.60e-05	185	56	4	42939b294ea3e871274d8b73124c850dc1904fd2
ToppCell	Severe_COVID-19-Myeloid-transitional_Macro\|Severe_COVID-19 / Disease group,lineage and cell class （2021.01.30）	ACOT11 SIRPB2 ROBO3 PRSS36	8.60e-05	185	56	4	f7ef0d7740b4cfedc38846e802898c402dc411fd
ToppCell	BAL-Severe-Myeloid-Macrophage-transitional_Macro\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	ACOT11 SIRPB2 ROBO3 PRSS36	8.60e-05	185	56	4	7a3612520ae4f0cd61480eadba31eecce001419d
ToppCell	10x_3'_v2v3-Non-neoplastic-Myeloid-TAM-BDM-TAM-BDM_INF-B\|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	AXL OTUD1 C3 C3AR1	9.15e-05	188	56	4	3f47395db7e6159fc95810545bad4b6e028464c5
ToppCell	MS-mono3\|MS / Condition, Cell_class and T cell subcluster	AXL OTUD1 C3 C3AR1	9.15e-05	188	56	4	a50a766c2f02e776c8e5c6e0833ec241c61831c4
ToppCell	MS-mono3-\|MS / Condition, Cell_class and T cell subcluster	AXL OTUD1 C3 C3AR1	9.15e-05	188	56	4	e8c1c2941ca4919e0097a65b692b7af8018e8886
ToppCell	RA-14._Fibroblast_III\|RA / Chamber and Cluster_Paper	MFHAS1 AXL NAV2 C3	9.34e-05	189	56	4	46e9a58aacd79db5a02898a8c7244e1884adcfd1
ToppCell	PND07-28-samps-Mesenchymal-Matrix_fibroblast\|PND07-28-samps / Age Group, Lineage, Cell class and subclass	NAV2 MACF1 FGFR4 PPM1K	9.34e-05	189	56	4	dc5164591dea45b420798b94dda211be03daa70c
ToppCell	PND07-28-samps-Mesenchymal-Matrix_fibroblast-FB-3\|PND07-28-samps / Age Group, Lineage, Cell class and subclass	LRATD1 NAV2 MACF1 PPM1K	9.53e-05	190	56	4	1196b8ea2c44c7c80f5ee589dd517e6a413f2077
ToppCell	PND01-03-samps-Mesenchymal-Matrix_fibroblast-MatrixFB-A\|PND01-03-samps / Age Group, Lineage, Cell class and subclass	NAV2 MACF1 FGFR4 PPM1K	9.73e-05	191	56	4	e7c605b56934d1383237c1f946dbccef25d91368
ToppCell	kidney_cells-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Cortical_Thick_Ascending_Limb_Cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	MUC15 NAV2 PPM1K PLXNB1	9.92e-05	192	56	4	8769b67d1cad1be65da3938f916e5bf88f88f6b8
ToppCell	Smart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-TAM-MG-TAM-MG_aging_sig-D\|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	AXL C3 C3AR1 SIRPB2	9.92e-05	192	56	4	5ea1a8119012eb8bc3100b739a0430377a8ac534
ToppCell	P07-Mesenchymal-mesenchymal_fibroblast-alveolar_fibroblast_Wnt2-pa\|P07 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	NAV2 MACF1 FGFR4 PPM1K	9.92e-05	192	56	4	0afb9dbe468e0be442c326e11c5fc0f699b32f23
ToppCell	TCGA-Endometrium-Primary_Tumor-Endometrial_Adenocarcinoma-Endometrioid-1\|TCGA-Endometrium / Sample_Type by Project: Shred V9	LRATD1 NAV2 GINS2 EXTL3	1.01e-04	193	56	4	c2673d86f7d7b849788036032a93a6d136a70040
ToppCell	10x_3'_v2v3-Non-neoplastic-Myeloid-TAM-MG-TAM-MG_pro-infl_I-G\|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	AXL OTUD1 C3 C3AR1	1.01e-04	193	56	4	26a55e98005163122d277480d1d44dd6910ab42f
ToppCell	Smart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-TAM-MG-TAM-MG_pro-infl_I\|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	AXL OTUD1 C3 C3AR1	1.05e-04	195	56	4	b6bf75669f267ecdc96818c7022db852e37a9fe1
ToppCell	PND01-03-samps-Mesenchymal-Matrix_fibroblast\|PND01-03-samps / Age Group, Lineage, Cell class and subclass	NAV2 MACF1 FGFR4 PPM1K	1.07e-04	196	56	4	54f4cf778f95a9ff662e5c7520916a25e605bf95
ToppCell	TCGA-Skin-Metastatic-Melanoma\|TCGA-Skin / Sample_Type by Project: Shred V9	C3 C3AR1 SIRPB2 SEC23A	1.12e-04	198	56	4	af4fb9eb2295c7b90624b38ba25619aa15254efa
ToppCell	normal_Lung-Fibroblasts-COL13A1+_matrix_FBs\|Fibroblasts / Location, Cell class and cell subclass	NAV2 MACF1 FGFR4 PPM1K	1.12e-04	198	56	4	e0e47cf65774191981840b22905b2094b95abe0f
ToppCell	TCGA-Skin-Metastatic\|TCGA-Skin / Sample_Type by Project: Shred V9	C3 C3AR1 SIRPB2 SEC23A	1.12e-04	198	56	4	ad39cce004867f083f8da1954e0cf5a263815184
ToppCell	TCGA-Skin-Metastatic-Melanoma-Skin_Cutaneous_Melanoma\|TCGA-Skin / Sample_Type by Project: Shred V9	C3 C3AR1 SIRPB2 SEC23A	1.12e-04	198	56	4	62cbf4b29e8af4983fb47a17f96da62682a5137e
ToppCell	10x_3'_v2v3-Non-neoplastic-Myeloid-TAM-BDM-TAM-BDM_anti-infl\|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	AXL OTUD1 C3 C3AR1	1.14e-04	199	56	4	5a291fa161c37ec31e9c43d9b3075c3e06333261
ToppCell	Smart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-TAM-MG-TAM-MG_pro-infl_II\|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	AXL OTUD1 C3 C3AR1	1.14e-04	199	56	4	e7faf7d0cb43cf93149c446e5f718f84fa85477c
ToppCell	Substantia_nigra-Macroglia-OLIGODENDROCYTE-O1-Tfr-Oligodendrocyte.Tfr.Slco3a1_(Slco3a1)-\|Substantia_nigra / BrainAtlas - Mouse McCarroll V32	CASQ1 FGFR4 CREB3L4	1.16e-04	75	56	3	574ed1836f6bf5fa38a53af0a05fa4437f68f36b
ToppCell	Substantia_nigra-Macroglia-OLIGODENDROCYTE-O1-Tfr-Oligodendrocyte.Tfr.Slco3a1_(Slco3a1)\|Substantia_nigra / BrainAtlas - Mouse McCarroll V32	CASQ1 FGFR4 CREB3L4	1.16e-04	75	56	3	45f7861bfeb1c6371b73cf2ea527801342e534bc
ToppCell	Smart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-TAM-BDM-TAM-BDM_MHC-F\|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	AXL C3 C3AR1 TESK1	1.16e-04	200	56	4	838f87cc55652512d240c5952ee4b3870fb2399f
ToppCell	LA-06._Ventricular_Cardiomyocyte_II\|World / Chamber and Cluster_Paper	AVPR2 AKR1C4 PLXNB1	1.86e-04	88	56	3	7232b13a9788f89600411222c0d93bdc3788816f
Disease	clonal hematopoiesis	JAK2 DNAAF3	1.47e-04	10	54	2	EFO_0010819
Disease	dystonia (is_implicated_in)	TSPOAP1 NUP54	2.95e-04	14	54	2	DOID:543 (is_implicated_in)
Disease	fertility measurement	LRATD1 NAV2	2.95e-04	14	54	2	EFO_0006923
Disease	glomerulonephritis (implicated_via_orthology)	AXL C3	4.39e-04	17	54	2	DOID:2921 (implicated_via_orthology)
Disease	parental emotion expression measurmement, conduct disorder	MFHAS1 PPM1K	9.60e-04	25	54	2	EFO_0004216, EFO_0008342
Disease	hepatocellular carcinoma (biomarker_via_orthology)	JAK2 C3 CDK4	1.03e-03	108	54	3	DOID:684 (biomarker_via_orthology)
Disease	digestive system infectious disorder	TYRO3 MFHAS1	1.04e-03	26	54	2	MONDO_0043424
Disease	myeloperoxidase measurement	TSPOAP1 SIRPB2	1.04e-03	26	54	2	EFO_0005243
Disease	Middle Cerebral Artery Embolus	SPHK2 C3	1.78e-03	34	54	2	C0751845
Disease	Embolic Infarction, Middle Cerebral Artery	SPHK2 C3	1.78e-03	34	54	2	C0751847
Disease	Left Middle Cerebral Artery Infarction	SPHK2 C3	1.78e-03	34	54	2	C0751846
Disease	Right Middle Cerebral Artery Infarction	SPHK2 C3	1.78e-03	34	54	2	C0751849
Disease	Thrombotic Infarction, Middle Cerebral Artery	SPHK2 C3	1.78e-03	34	54	2	C0751848
Disease	Middle Cerebral Artery Occlusion	SPHK2 C3	1.78e-03	34	54	2	C0740391
Disease	Infarction, Middle Cerebral Artery	SPHK2 C3	1.78e-03	34	54	2	C0740392
Disease	Middle Cerebral Artery Thrombosis	SPHK2 C3	1.78e-03	34	54	2	C0740376
Disease	Middle Cerebral Artery Syndrome	SPHK2 C3	1.78e-03	34	54	2	C0238281

Protein segments in the cluster

Peptide	Gene	Start	Entry
ILLPPILWRDELEPC	VANGL1	131	Q8TAA9
LWVDPNSPVLLEDPV	AKR1C4	226	P17516
PPDGWELIEPTLDEL	BUD31	11	P41223
DAWPFLLPVNLKLVP	BAZ2B	2081	Q9UIF8
SLDLPLDPLWEFPRD	FGFR4	451	P22455
LGVLPLSWDIPELVN	C3	186	P01024
LDADDQPQLLPWIRP	ACOT11	326	Q8WXI4
LDPSNEALIWLDPLP	DNHD1	3556	Q96M86
WIAPELRLQSDDILP	DHX30	371	Q7L2E3
TDLLSQPWNEPPVIL	C3AR1	11	Q16581
IWDNRIDEPILLPPS	PPM1K	66	Q8N3J5
SVVLAWEPPPEQVEL	TSPOAP1	806	O95153
ILQERIPWVPPECIE	JAK2	711	O60674
WLLEELLRPDCPEPA	OTUD1	166	Q5VV17
PWNAPIADEDLLPIS	MUC15	121	Q8N387
PLVEELNVLLQEWPG	MFHAS1	961	Q9Y4C4
QLPLDRLLIDWPTPE	IL12RB2	686	Q99665
PLEATPILEWPGIQL	PLXNB1	391	O43157
EPVLEEWIPVLQRPS	MACF1	821	O94854
LDWLLLGPAAPPRQE	LRP3	101	O75074
EPGDLLELLWLQPAP	LRATD1	121	Q96KN4
DPQEPPWVEVLVEIL	MYBBP1A	641	Q9BQG0
LALPVWRPPDFEEEL	OBSCN	6006	Q5VST9
LLQNPPAGVDPIIWE	NUP54	296	Q7Z3B4
VQEADPLPLPWVLQE	PRSS36	181	Q5K4E3
PLPLPWVLQEVELRL	PRSS36	186	Q5K4E3
VPEPDRLEEQLPWLS	DNAAF3	141	Q8N9W5
IFDLIGLPPEDDWPR	CDK4	226	P11802
LPSEDLLWPDIGVPI	EXTL3	701	O43909
LSIIWIDPDDFPLLV	CASQ1	316	P31415
RLLPQWIPLLAECPA	DENND5B	1216	Q6ZUT9
WRNPLPPIDLADIED	C9orf40	156	Q8IXQ3
PDLLDAWLEPPEDIF	CREB3L4	6	Q8TEY5
LLGLSEWPEEQPLLF	OR1N2	31	Q8NGR9
WPVPIVPVLAEENLE	RTL5	56	Q5HYW3
LLELAEQPPDRPLWR	SYT3	406	Q9BQG1
QELEVLSVLPPGWQP	SZT2	56	Q5T011
EPLPPEILEVILSEW	AK9	1096	Q5TCS8
PDWTQPLDLPQLEIR	PKDREJ	271	Q9NTG1
FNPGLPVEVPLWLAI	GINS2	36	Q9Y248
QHEWPPLLQLRPEDV	NAV2	2406	Q8IVL1
TLEPPLPEDTVLWEL	PSD4	286	Q8NDX1
TDLLGELQRDPWPVP	SEC23A	241	Q15436
EPLSPIPIDHWNLER	SLX4	1431	Q8IY92
PVLPPTITDQIRLWE	GTF2H4	381	Q92759
EPDLWIIQPQELVLG	SIRPB2	156	Q5JXA9
PLPPDWVTLEGDFVL	SPHK2	526	Q9NRA0
PLPPPEEEASWALEL	ROBO3	1271	Q96MS0
PEPVDLLWLQDAVPL	AXL	166	P30530
EPDGLPLLEWNLCLE	MYCBPAP	711	Q8TBZ2
EVIVLPPGEWDPNIR	SLC4A5	396	Q9BY07
PLLIECWVEAVPPQL	TEX10	326	Q9NXF1
LEWILEQLPEPAPLT	TESK1	311	Q15569
IPWSIPLEAEDIPIV	PPIP5K2	356	O43314
IEEPFFSPLWPLLLA	VPS9D1	446	Q9Y2B5
EWEEVIPEAPLEGPL	TYRO3	341	Q06418
WDPEAPLEGAPFVLL	AVPR2	296	P30518